≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Use of dimethyl fumarate

Endpoint Browser

MSMED_DIMETHYL_FUMARATE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — N07XX09

1 out of 7 registries used, show all original rules.

326

4. Check minimum number of events

Min. number of events 3
326

5. Include endpoints

None

326

6. Filter based on genotype QC (FinnGen only)

326

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 326 260 66
Unadjusted period prevalence (%) 0.08 0.09 0.03
Median age at first event (years) 40.90 40.69 41.69

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
294
Matched controls
2939
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
109
Kela drug reimbursment
Multiple sclerosis
10110.0
323.0
291
16
G35
ICD-10 Finland
Multiple sclerosis
+∞
323.0
294
24
N07XX09
ATC
[U] dimethyl fumarate; oral
+∞
323.0
294
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
323.0
294
13
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
12563.2
323.0
288
13
L04AX07
ATC
dimethyl fumarate; oral
3584.2
296.9
236
*
L03AB07
ATC
interferon beta-1a; parenteral
1562.9
175.0
153
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
47.9
151.5
194
114
L03AX13
ATC
glatiramer acetate; parenteral
317.1
121.9
116
6
N86
ICPC
Multiple sclerosis
164.6
98.2
99
9
H46
ICD-10 Finland
Optic neuritis
107.1
89.8
95
13
TAB00
NOMESCO Finland
Lumbar puncture
27.1
78.8
112
65
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
136.5
77.5
80
8
L04AA31
ATC
teriflunomide; oral
316.2
74.0
72
*
L03AB08
ATC
interferon beta-1b; parenteral
224.2
69.4
69
*
XA800
NOMESCO Finland
Neuropsychological investigation
23.9
55.6
81
46
2AB04
NOMESCO Finland
NA
639.9
55.5
53
*
164
Kela drug reimbursment
Fingolimod
153.5
49.5
51
*
N04BB01
ATC
amantadine; oral
43.7
44.0
54
15
353
Kela drug reimbursment
Cladribine and fingolimod
167.1
42.0
43
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
25.9
40.7
57
27
XCK00
NOMESCO Finland
Perimetry
14.2
38.5
68
61
ZX120
NOMESCO Finland
Intravenous
10.1
38.5
82
108
L04AA27
ATC
fingolimod; oral
204.3
35.6
36
*
G04BD12
ATC
mirabegron; oral
14.2
34.9
61
53
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
30.2
33.0
44
17
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
8.1
32.3
79
128
XKD00
NOMESCO Finland
Uroflowmetry
11.6
31.6
61
65
XKD06
NOMESCO Finland
Physiologic investigation of micturition
27.8
31.6
43
18
N06BA07
ATC
modafinil; oral
76.5
30.6
34
5
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
335.0
30.4
30
*
M03BX01
ATC
baclofen; systemic
24.1
28.3
40
19
G04BD09
ATC
trospium; oral
33.6
25.6
33
11
R1250
NOMESCO Finland
Evaluation of functional capability
18.8
24.8
38
23
R20.2
ICD-10 Finland
Paraesthesia of skin
7.2
24.5
63
107
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.1
23.3
83
211
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
19.1
22.4
34
20
L03AB13
ATC
peginterferon beta-1a; parenteral
+∞
21.1
20
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.8
20.9
63
131
TKC22
NOMESCO Finland
Catheterisation instruction
38.8
20.2
25
7
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.9
20.1
37
35
H02AB04
ATC
methylprednisolone; systemic
4.5
19.4
76
210
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
8.7
19.2
42
55
Z3231
NOMESCO Finland
Registered nurse
3.5
18.4
107
413
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
22.6
17.6
25
12
Z3226
NOMESCO Finland
Physiotherapist
4.0
17.3
79
250
R4110
NOMESCO Finland
Physiotherapy
3.3
16.2
100
397
Z2445
NOMESCO Finland
Psychologist
6.5
15.5
41
71
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.6
15.3
40
68
G04BD08
ATC
solifenacin; oral
9.3
14.1
29
34
R4150
NOMESCO Finland
Neuropsychological rehabilitation
21.3
14.0
20
10
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
78.9
13.7
15
*
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
13.6
13
*
C10AC01
ATC
colestyramine; oral
10.5
13.5
26
27
4AA23
NOMESCO Finland
NA
73.1
12.7
14
*
UKC02
NOMESCO Finland
Cystoscopy
4.5
12.4
45
113
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
11.5
11
*
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
36.6
11.4
14
*
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
26.2
11.3
15
6
N05CF01
ATC
zopiclone; oral
2.6
11.2
96
457
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.1
11.2
45
125
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.0
11.1
36
80
XCD10
NOMESCO Finland
Electrophysiological examination of eye
10.2
10.9
21
22
H53.2
ICD-10 Finland
Diplopia
10.2
10.9
21
22
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
18.7
10.8
16
9
XKC03
NOMESCO Finland
Water cystometry
8.5
10.8
23
29
G04BD11
ATC
fesoterodine; oral
22.5
10.8
15
7
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
8.7
10.5
22
27
G04BD07
ATC
tolterodine; oral
8.7
10.5
22
27
R35
ICD-10 Finland
Polyuria
7.6
10.5
24
34
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
19.7
10.4
15
8
G04BD04
ATC
oxybutynin; oral, transdermal
7.0
10.0
24
37
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
7.8
9.9
22
30
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
9.4
9
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
8.4
9.0
19
24
N03AX12
ATC
gabapentin; oral
2.9
8.9
57
222
R4120
NOMESCO Finland
Occupational therapy
4.5
8.7
30
72
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
7.7
8.6
19
26
H53.1
ICD-10 Finland
Subjective visual disturbances
4.4
8.3
29
71
N29
ICPC
Neurological sympt/complt other
8.5
8.2
17
21
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.9
8.2
33
92
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.1
8.2
25
53
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
17.8
8.1
12
7
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.8
8.1
26
58
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
46.2
7.8
9
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.3
7.7
28
71
N03AE01
ATC
clonazepam; systemic
4.0
7.6
30
82
G04CA02
ATC
tamsulosin; oral
4.4
7.4
26
64
4AA36
NOMESCO Finland
NA
+∞
7.3
7
*
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
30.8
7.2
9
*
Z2221
NOMESCO Finland
Medical doctor
2.1
7.1
100
581
N03AX16
ATC
pregabalin; oral
2.3
7.0
73
371
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.5
6.8
31
97
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
6.5
47
196
L04AA40
ATC
cladribine; oral
71.3
6.5
7
*
R03CA02
ATC
ephedrine; oral
71.3
6.5
7
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
71.3
6.5
7
*
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
+∞
6.3
6
*
L01BB04
ATC
cladribine; systemic
+∞
6.3
6
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
27.3
6.3
8
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
27.3
6.3
8
*
L28
ICPC
Limited function/disability (L)
3.1
6.2
32
110

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014148) Varicella zoster virus Ab [Titer] in Serum
95
55
23.96
121.01
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
93
55
23.26
117.16
1.2
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
265
806
13.23
99.14
16.7
5.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
233
699
9.18
84.57
5.2
2.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
300
1185
20.20
83.11
20.4
5.3
%
0.8
0.7
2.91
300
1114
(3019069) Monocytes/100 leukocytes in Blood
301
1243
19.54
78.01
20.6
5.5
%
9.5
7.8
25.97
301
1182
(3006504) Eosinophils/100 leukocytes in Blood
300
1241
18.77
77.35
20.6
5.2
%
2.9
2.8
0.32
300
1168
(3018010) Neutrophils/100 leukocytes in Blood
301
1282
18.58
74.23
20.2
5.1
%
62.1
56.5
21.84
301
1217
(3002030) Lymphocytes/100 leukocytes in Blood
302
1292
19.17
74.12
20.6
5.3
%
23.6
29.7
28.20
302
1230
(3026782) Osmolality of Urine
160
389
7.11
69.22
3.4
2.0
mosm/kgh2o
576.7
574.9
0.03
155
328
(3030467) Casts [#/volume] in Urine by Automated count
189
549
6.81
67.42
4.7
2.2
e6/l
0.1
0.3
3.65
182
398
(36304419) Bacteria [Presence] in Urine
190
562
6.71
66.21
4.6
2.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
197
606
6.69
65.64
4.6
2.3
e6/l
11.2
79.4
1.74
192
445
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
75
81
11.73
65.40
1.8
1.7
iu/ml
0.0
0.0
—
6
11
(3011412) CD3 cells [#/volume] in Blood
47
22
24.79
64.16
3.7
2.7
e9/l
1.1
1.3
0.49
23
13
(3005719) IgG [Mass/volume] in Serum or Plasma
109
198
7.77
62.11
4.1
2.4
g/l
9.7
10.2
0.98
101
185
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
41
16
29.17
59.74
2.6
2.9
%
15.2
11.9
0.40
25
11
(3018095) Leukocytes [#/volume] in Urine
212
769
6.02
56.47
5.8
2.8
e6/l
16.5
67.5
1.15
195
486
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
37
16
25.96
51.79
2.6
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
118
299
5.62
46.43
3.6
2.1
e6/l
0.7
0.9
0.54
79
157
(3021589) Normoblasts [#/volume] in Blood
244
1146
5.49
43.60
19.1
7.2
e9/l
0.0
0.0
0.10
233
941
(40758558) Short blood count panel - Blood
172
629
4.67
42.37
13.1
5.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
297
1782
8.49
35.96
8.9
3.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
30
21
15.63
33.50
1.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
100
285
4.62
32.99
3.9
2.1
e6/l
2.8
3.7
0.52
61
143
(3015736) pH of Urine
204
964
3.98
32.78
4.7
2.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
217
1076
4.04
32.30
2.4
2.2
nmol/l
94.8
72.1
18.58
209
1015
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
44
59
8.47
31.78
1.2
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
23
11
22.42
30.56
4.2
2.8
e9/l
0.2
0.2
0.14
23
11
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
35
37
10.48
30.27
1.1
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
27
22
13.29
27.57
5.0
1.6
e6/l
807.3
729.9
—
15
7
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
279
4.20
27.51
1.4
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
228
1249
3.75
27.43
7.8
4.0
estimate
0.0
0.0
0.50
47
258
(3035350) Ketones [Presence] in Urine by Test strip
227
1245
3.71
27.15
5.9
2.8
estimate
0.0
0.0
0.00
47
256
(3009261) Glucose [Presence] in Urine by Test strip
228
1259
3.70
26.87
5.8
2.9
estimate
0.0
0.0
0.00
48
252
(4027681)
26
21
13.37
26.66
1.1
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
132
523
3.56
26.55
5.3
2.9
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
23
18
13.67
23.96
3.5
2.9
%
52.4
43.9
—
7
5
(3026008) Bacteria identified in Urine by Culture
138
593
3.30
23.90
4.1
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
51
111
5.26
22.84
1.3
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
27
30
9.72
22.39
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
22
18
13.03
22.29
1.1
1.1
miu/ml
1786.6
1720.3
0.07
22
18
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
33
8.83
20.81
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
22
21
11.16
20.21
1.0
1.1
u/l
0.9
1.1
—
5
12
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
26
33
8.47
19.43
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
108
460
3.02
18.21
1.4
1.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
326
2870
+∞
16.88
13.8
9.6
umol/l
62.9
68.4
14.30
326
2870
(3052851) Hemolysis interference index of Serum or Plasma
27
51
5.68
13.97
1.5
2.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
52
171
3.43
13.23
7.8
3.9
%
0.2
0.9
—
6
33
(3021440) Promyelocytes/100 leukocytes in Blood
52
173
3.39
12.99
7.8
4.2
%
0.0
0.2
—
7
41
(21494814) CD8 cells/100 lymphocytes in Specimen
16
5
33.52
12.69
2.2
3.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
16
5
33.52
12.69
2.2
3.8
%
8.6
7.8
—
16
5
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
30
68
4.76
12.66
1.0
1.2
e6/l
17.5
222.7
1.08
25
54
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
68
4.76
12.66
1.0
1.1
e6/l
13.8
4.6
1.75
24
51
(3017181) Myelocytes/100 leukocytes in Blood
53
185
3.23
12.23
7.7
4.0
%
0.6
1.1
—
8
48
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
7
23.93
11.68
5.3
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
49
170
3.22
11.39
8.2
4.1
%
0.0
0.2
—
6
38
(40760892) CBC W Ordered Manual Differential panel - Blood
126
704
2.29
11.26
14.3
4.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
53
196
3.03
11.05
2.8
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
60
4.62
10.72
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
132
772
2.19
10.38
1.6
1.7
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
15
8
19.57
10.36
1.0
1.0
mg/g
5.4
5.6
—
10
8
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
15
9
17.38
9.97
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
36
5.54
9.76
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
208
2579
0.47
9.42
2.7
3.0
mmol/l
1.2
1.2
0.42
196
2465
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
54
4.51
9.28
3.8
3.6
e9/l
3.4
4.4
1.71
23
54
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
52
211
2.74
9.10
1.3
1.2
—
22.4
—
0
8
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
55
4.42
9.07
3.9
3.7
%
61.2
58.3
0.63
23
55
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
145
928
2.01
8.59
3.7
3.0
u/l
26.0
28.2
0.62
137
890
(3002385) Erythrocyte distribution width [Ratio]
292
2437
2.90
8.47
25.2
11.3
%
13.2
13.4
2.02
292
2399
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
223
2676
0.47
8.47
3.0
3.3
mmol/l
1.6
1.5
3.10
205
2566
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
227
2705
0.47
8.37
3.1
3.6
mmol/l
3.0
2.9
0.36
210
2585
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
172
1189
1.95
7.97
3.6
4.9
umol/l
9.1
10.0
0.98
165
1125
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
227
2683
0.49
7.43
3.0
3.4
mmol/l
4.9
4.8
1.08
212
2577
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
293
2500
2.70
7.18
9.8
7.7
ml/min/173m2
103.4
94.5
20.80
270
2035
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
53
247
2.37
6.92
2.8
2.2
u/l
2289.4
2837.6
—
6
103
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
145
992
1.83
6.55
7.1
2.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
140
958
1.81
6.24
1.7
2.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
8
12.84
6.12
1.0
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
78
1206
0.54
5.44
1.9
2.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
5
16.34
5.43
1.8
3.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
100
652
1.77
5.05
2.6
1.4
g/l
1.8
2.2
2.45
76
426
(3016018) Differential panel - Cerebral spinal fluid
12
28
4.41
4.86
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
140
2.43
4.79
7.8
3.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
326
3144
+∞
4.66
30.0
14.3
e9/l
259.7
264.5
0.72
326
3094
(3000963) Hemoglobin [Mass/volume] in Blood
326
3149
+∞
4.48
30.0
14.3
g/l
137.4
136.3
1.11
326
3122
(3026361) Erythrocytes [#/volume] in Blood
326
3148
+∞
4.47
30.0
14.2
e12/l
4.6
4.6
0.25
326
3096
(3024731) MCV [Entitic volume]
326
3147
+∞
4.46
29.9
14.2
fl
90.5
89.9
2.41
326
3122
(3035941) MCH [Entitic mass]
326
3147
+∞
4.46
29.8
14.2
pg
30.3
30.0
2.17
326
3121
(3029937) Albumin [Presence] in Urine by Test strip
97
648
1.71
4.42
8.7
3.2
estimate
0.0
0.0
0.80
47
256
(3041096) Erythrocytes [Presence] in Urine by Automated
110
764
1.66
4.32
5.6
2.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
326
3150
+∞
4.26
30.0
14.3
e9/l
5.6
6.7
25.85
326
3095
(3013826) Glucose [Moles/volume] in Serum or Plasma
164
1263
1.60
4.21
3.1
3.8
mmol/l
6.2
6.3
0.44
154
1127
(3019150) Specific gravity of Urine by Refractometry
83
541
1.72
4.11
6.8
3.0
kg/l
1.0
1.0
—
8
67
(3024561) Albumin [Mass/volume] in Serum or Plasma
115
855
1.53
3.24
3.2
3.9
g/l
39.0
37.5
2.33
104
807
(3023511) Choriogonadotropin [Units/volume] in Urine
30
152
2.07
3.22
1.6
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
219
1870
1.52
3.12
4.3
6.2
u/l
67.6
71.9
1.56
207
1772
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
300
2771
2.04
3.12
9.4
9.3
mg/l
21.0
18.2
0.61
199
2089
(3023103) Potassium [Moles/volume] in Serum or Plasma
286
2609
1.78
2.99
7.7
8.8
mmol/l
3.9
3.9
0.26
277
2529
(3019550) Sodium [Moles/volume] in Serum or Plasma
285
2600
1.76
2.95
7.6
8.7
mmol/l
139.9
139.6
1.90
278
2532
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
202
2294
0.69
2.69
3.0
4.0
mmol/mol
36.7
37.6
0.78
193
2199
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
270
1.73
2.67
2.3
2.2
umol/l
5.1
6.2
0.32
34
233
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
25
3.67
2.59
1.0
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
12
5.07
2.41
1.2
3.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
8
6.33
2.38
1.2
3.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
185
0.36
2.37
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
226
2486
0.70
2.17
2.5
3.3
mmol/l
5.5
5.6
0.84
215
2346
(40761536) Microorganisms panel - Urine sediment
35
220
1.66
1.98
8.4
3.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
274
0.49
1.90
1.2
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
31
475
0.62
1.81
3.7
4.0
mg/mmol
5.1
11.6
0.67
19
298
(3000330) Specific gravity of Urine by Test strip
16
81
2.03
1.78
3.1
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
30
458
0.62
1.72
2.6
3.3
mg/l
28.5
384.5
0.98
16
293
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
47
0.00
1.72
0.0
5.7
—
373.8
—
0
41
(3004588) Protein electrophoresis panel - Serum or Plasma
16
83
1.98
1.67
1.1
2.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
19
3.20
1.67
1.8
4.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
20
335
0.57
1.66
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
25
2.84
1.66
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
25
2.84
1.66
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
25
2.84
1.66
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
17
297
0.55
1.63
1.1
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
18
309
0.56
1.63
2.5
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
43
2.37
1.62
1.5
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
96
772
1.35
1.61
1.4
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
37
530
0.66
1.60
1.3
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
26
2.73
1.59
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
26
2.73
1.59
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
26
2.73
1.59
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
205
0.47
1.57
1.5
1.4
—
—
—
0
0
(3019225) pH of Specimen
9
184
0.47
1.56
3.3
4.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
275
2580
1.42
1.51
27.2
11.7
g/l
333.9
333.2
0.86
275
2567
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
26
397
0.63
1.50
1.2
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
234
0.54
1.40
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
234
0.54
1.40
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
233
0.54
1.38
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
233
0.54
1.38
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
41
2.23
1.38
3.1
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
17
2.97
1.36
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
40
0.00
1.33
0.0
2.0
—
1.0
—
0
35
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
420
0.66
1.33
2.1
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
62
783
0.74
1.30
1.9
1.9
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
17
99
1.76
1.30
1.5
1.4
u/l
22.1
21.0
0.05
12
83
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
18
2.80
1.29
1.8
1.3
pg
31.2
32.3
—
5
18
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
159
0.49
1.28
1.8
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
14
77
1.85
1.27
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
247
0.59
1.20
1.4
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
107
1245
0.79
1.19
3.4
3.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
102
1.70
1.18
1.4
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
31
432
0.69
1.18
1.8
2.3
ug/g
67.3
72.7
0.08
19
348
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
184
0.53
1.17
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
196
0.55
1.17
1.3
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
79
947
0.78
1.12
1.5
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
192
0.56
1.09
1.3
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
40
526
0.73
1.09
1.3
1.3
u/ml
2.1
9.0
2.17
16
234
(3005033) Fetal Nuchal fold Thickness US
11
191
0.56
1.08
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
234
2484
0.79
1.06
3.4
3.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
133
0.52
1.01
1.1
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
35
2.02
1.00
4.9
2.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
46
584
0.75
1.00
3.1
3.1
mmol/l
8.5
8.1
0.23
39
516
(3001122) Ferritin [Mass/volume] in Serum or Plasma
129
1448
0.82
0.98
2.4
2.9
ug/l
102.7
65.8
0.68
121
1387
(3022145) Colonoscopy Study observation
20
290
0.67
0.95
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
11
183
0.59
0.94
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
153
0.58
0.91
2.6
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
43
543
0.76
0.90
1.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
51
629
0.78
0.90
1.3
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
20
140
1.46
0.79
4.0
2.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
16
107
1.52
0.77
1.9
2.4
e9/l
68.8
76.9
0.33
11
78
(3015377) Calcium [Moles/volume] in Serum or Plasma
83
716
1.21
0.77
1.7
2.8
mmol/l
2.4
2.3
0.45
76
664
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
28
0.00
0.76
0.0
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
284
2741
1.28
0.76
22.9
9.9
%
41.2
40.5
2.77
236
2339
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
53
1.72
0.76
1.0
1.1
—
—
—
0
0
(4062490)
5
25
2.02
0.73
1.0
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
14
205
0.67
0.72
1.9
5.4
mmol/l
0.9
1.0
0.96
14
190
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
40
1.77
0.71
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
40
1.77
0.71
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
41
1.72
0.70
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
28
214
1.34
0.69
2.4
2.2
u/l
25.1
33.8
1.11
22
185
(36660697) Celiac disease serology panel - Serum
34
268
1.30
0.69
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
49
586
0.81
0.68
1.9
1.8
—
—
—
0
0
(3013512) EKG study
41
500
0.79
0.67
2.3
2.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
172
1.36
0.65
1.3
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
50
417
1.24
0.65
3.4
3.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
267
2571
1.21
0.65
4.6
4.7
mu/l
1.7
2.1
0.55
255
2463
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
29
1.74
0.64
1.2
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
182
1.34
0.63
1.3
1.3
miu/ml
118.2
260.2
—
10
92
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
96
1.48
0.62
1.1
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
198
0.69
0.62
1.1
1.2
—
—
—
0
0
(4010399)
9
139
0.64
0.62
1.9
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
50
1.61
0.61
1.0
2.3
g/l
2.5
2.9
—
8
41
(40768443) Skin Pathology biopsy report
13
88
1.50
0.61
1.5
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
52
1.55
0.60
1.0
2.3
g/l
6.1
6.9
—
8
44
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
52
1.55
0.60
1.0
2.3
g/l
3.3
3.7
—
8
40
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
52
1.55
0.60
1.0
2.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.2
—
0.1
—
0
7
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
8
55
1.47
0.56
1.0
1.3
—
110.2
—
0
15
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
65
1.56
0.56
1.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
52
604
0.83
0.55
1.6
1.7
mg/l
0.5
0.7
0.53
40
443
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
134
0.66
0.53
1.0
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
18
235
0.75
0.51
3.3
3.3
%
28.0
31.3
0.76
13
178
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
65
1.40
0.51
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
106
0.65
0.49
1.1
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
7
106
0.65
0.49
1.1
2.8
kpa
4.8
5.1
—
7
100
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
47
545
0.84
0.49
1.8
2.0
mg/l
2.7
2.9
0.23
37
486
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
128
1.35
0.48
1.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
119
0.66
0.46
2.1
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
83
0.60
0.46
1.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
414
0.83
0.46
1.6
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
37
435
0.83
0.45
1.7
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
69
1.46
0.44
1.4
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
48
417
1.18
0.44
1.3
1.6
pmol/l
551.5
58441978.6
1.07
43
385
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
31
1.62
0.43
1.6
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
167
1.28
0.43
1.3
1.7
—
—
—
0
0
(3020891) Body temperature
8
57
1.41
0.42
2.3
5.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
32
1.57
0.42
1.2
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
96
1.37
0.42
2.2
2.0
iu/l
8.6
6.8
—
5
37
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(4146454)
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
59
1.36
0.41
1.0
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.0
—
3.8
—
0
16
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
16
0.00
0.41
0.0
2.5
—
117.9
—
0
16
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
17
0.00
0.41
0.0
2.1
—
105.2
—
0
17
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
17
0.00
0.41
0.0
2.1
—
4.0
—
0
17
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
40
345
1.18
0.40
1.7
2.7
ng/l
15.1
492.0
1.09
15
170
(40765089) Chromosome analysis panel - Blood by G-banded
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
19
0.00
0.39
0.0
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
102
1099
0.90
0.39
1.8
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
532
0.86
0.38
1.2
1.3
iu/ml
11.5
24.2
—
8
172
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
55
615
0.87
0.38
1.5
1.6
mmol/l
1.6
1.4
0.43
46
554
(3000991) Gas panel - Venous blood
15
116
1.31
0.37
11.7
6.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
80
0.62
0.35
1.2
3.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
42
1.44
0.35
2.7
1.7
ug/l
213.5
187.9
—
6
37
(3043409) Potassium [Moles/volume] in Arterial blood
6
42
1.44
0.35
1.8
4.7
mmol/l
4.1
3.7
—
6
37
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.2
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
80
735
1.12
0.34
1.3
1.3
u/ml
0.5
2.4
1.67
14
200
(3045424) Erythrocytes [Presence] in Urine
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.2
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
79
854
0.90
0.32
4.9
4.8
mmol/l
1.2
1.2
0.30
71
793
(3002256) Pathology report gross observation
35
306
1.16
0.31
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
48
430
1.14
0.31
1.4
1.4
titre
410.0
459.3
0.20
16
89
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
83
769
1.11
0.31
1.5
1.7
pmol/l
100.4
97.7
0.19
42
447
(3007930) Methemoglobin/Hemoglobin.total in Blood
7
53
1.33
0.31
1.7
5.7
%
0.7
0.9
—
7
48
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
54
1.30
0.30
1.7
5.7
%
2.0
1.7
—
7
49
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
302
0.85
0.30
1.4
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
56
1.26
0.29
1.0
1.3
—
1.2
—
0
6
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
56
1.26
0.29
1.1
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
8
109
0.73
0.29
1.4
1.6
g/l
1.1
1.2
—
8
103
(4035726)
13
162
0.79
0.29
1.2
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
30
343
0.86
0.29
1.7
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
187
1.19
0.27
1.5
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
46
417
1.12
0.26
1.4
1.4
nmol/l
19.0
20.9
0.44
41
377
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
198
1.17
0.25
1.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
299
2954
1.15
0.24
10.6
8.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
115
1.23
0.24
1.9
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
34
304
1.13
0.24
1.7
2.0
umol/l
16.4
15.7
0.19
29
283
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
232
0.85
0.23
5.1
4.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
1.1
—
966.0
—
0
5
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
4.5
—
6.6
—
0
11
(3043410) Blood group antigens tested for on Red Blood Cells
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
10
0.00
0.21
0.0
3.4
—
127.5
—
0
10
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3016750) Collection duration of Urine
0
10
0.00
0.21
0.0
1.1
—
552.6
—
0
5
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
10
0.00
0.21
0.0
3.4
—
2674.0
—
0
10
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
78
827
0.93
0.21
1.6
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
199
1938
1.07
0.21
2.3
3.4
mm/h
6.7
8.3
2.66
185
1832
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
89
1.24
0.21
2.2
2.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
13
0.00
0.21
0.0
1.0
—
147.2
—
0
13
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
13
0.00
0.21
0.0
1.0
—
95.3
—
0
6
(3034426) Prothrombin time (PT)
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.3
—
0
7
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
13
0.00
0.21
0.0
1.0
—
115.7
—
0
6
(3015171) Extractable nuclear Ab [Units/volume] in Serum
16
136
1.19
0.20
1.2
1.3
—
1.1
—
0
11
(3006653) Thiamine [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.6
—
176.6
—
0
14
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
68
723
0.92
0.20
2.0
2.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
49
1.23
0.20
1.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
65
692
0.92
0.20
1.6
2.5
ng/l
211.8
17.6
0.62
27
278
(3025941) Bacteria identified in Stool by Culture
20
175
1.15
0.19
1.2
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
6
53
1.13
0.19
1.0
1.0
—
0.0
—
0
14
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
53
1.13
0.19
1.5
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
92
964
0.94
0.18
5.2
5.5
mmol/l
1.2
1.2
1.05
81
823
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
15
174
0.86
0.18
1.2
2.4
g/l
0.2
0.2
0.16
15
168
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
101
1.20
0.17
1.1
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
177
1.14
0.16
1.5
1.9
ml/min/173m2
91.8
80.7
—
5
62
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
27
296
0.90
0.15
1.3
1.2
iu/ml
72.8
185.1
—
9
122
(3019060) Gas panel - Arterial blood
9
79
1.14
0.15
2.1
4.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
79
1.14
0.15
4.7
7.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
83
1.09
0.15
1.8
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
83
1.09
0.15
1.1
1.3
—
3.1
—
0
8
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
62
652
0.94
0.14
1.8
1.9
—
—
—
0
0
(3012544) pH of Venous blood
14
122
1.15
0.14
1.4
2.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
23
252
0.91
0.13
1.8
2.0
%
25.4
25.9
0.04
16
219
(3032080) INR in Blood by Coagulation assay
64
670
0.94
0.13
1.7
5.2
inr
1.0
1.0
0.64
19
231
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
268
1.09
0.12
1.4
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
95
1.16
0.12
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
20
183
1.10
0.10
1.1
1.1
—
195.0
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
155
0.90
0.09
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
206
0.92
0.09
6.4
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
63
0.79
0.08
1.4
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
7
64
1.10
0.08
1.4
2.9
%
53.8
55.7
—
7
64
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
64
1.10
0.08
2.7
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
23
215
1.08
0.08
1.8
3.1
%
20.2
22.9
—
10
59
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
74
0.81
0.07
1.3
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
76
1.05
0.07
1.0
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
84
1.07
0.07
1.1
1.2
—
29.2
—
0
15
(3002523) Influenza virus A Ag [Presence] in Specimen
8
91
0.88
0.07
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
91
0.88
0.07
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
183
0.93
0.06
1.8
2.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
148
1.09
0.06
7.3
2.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
14
152
0.92
0.06
12.9
7.4
mmol/l
2.5
0.9
—
6
112
(3014007) Fractional oxyhemoglobin in Arterial blood
10
90
1.11
0.05
16.6
8.5
%
94.3
94.3
—
10
90
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
220
2218
0.98
0.05
4.0
4.2
pmol/l
14.6
14.3
1.21
207
2108
(3028300) Cannabinoids [Presence] in Urine
20
210
0.95
0.03
6.1
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
71
723
0.98
0.03
1.7
2.2
u/l
50.3
54.6
0.84
64
681
(3028707) Methadone [Presence] in Urine by Screen method
10
92
1.09
0.03
4.2
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
209
0.95
0.03
6.1
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
108
0.92
0.03
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
208
0.96
0.02
6.1
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
28
287
0.97
0.01
1.6
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
12
126
0.95
0.00
3.4
3.6
ng/l
72.0
74.2
0.05
12
118
(3044889) 12 lead EKG panel
160
1606
0.99
0.00
2.6
2.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
168
1.01
0.00
6.9
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
103
0.97
0.00
1.1
2.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
16
163
0.98
0.00
1.8
2.0
ug/l
0.6
0.6
—
8
66
(3016879) Cocaine [Presence] in Urine
19
195
0.97
0.00
6.3
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
27
275
0.98
0.00
1.3
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
29
286
1.02
0.00
1.2
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
14
136
1.03
0.00
12.6
7.9
%
96.7
96.5
0.09
14
129
(3027801) Oxygen [Partial pressure] in Arterial blood
15
154
0.97
0.00
12.3
7.3
kpa
12.9
13.8
0.22
15
147
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
15
154
0.97
0.00
12.3
7.3
kpa
5.1
5.1
0.01
15
146
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
60
1.00
0.00
1.8
1.8
%
13.0
13.2
—
6
60
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
203.1
—
0
8
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
114.4
—
0
8
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
12.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
51
0.98
0.00
2.4
4.8
mmol/l
1.0
1.1
—
5
44
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
79
0.88
0.00
1.4
2.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
8
79
1.01
0.00
1.6
2.3
ng/l
89.2
62.6
—
8
71
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
5
0.00
0.00
0.0
3.0
—
17.0
—
0
5
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
9
91
0.99
0.00
6.0
6.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
2.0
—
7.2
—
0
9
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
2.2
—
47.4
—
0
5
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
7
0.00
0.00
0.0
35.4
—
6.4
—
0
7
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
7.9
—
0
9
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
35.1
—
0
7
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
59
0.85
0.00
1.0
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
16.9
—
0
6
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
88
0.91
0.00
1.8
5.0
mmol/l
25.7
24.7
—
8
88
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
13.9
—
0
7
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
1.2
—
0
7
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
17.0
—
0
6
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MSMED_DIMETHYL_FUMARATE – Use of dimethyl fumarate

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).